Cigna Group (NYSE:CI) Given New $337.00 Price Target at Royal Bank Of Canada

Cigna Group (NYSE:CI) had its price objective upped by Royal Bank Of Canada from $333.00 to $337.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the health services provider’s stock.

Several other equities analysts have also recently issued reports on CI. Cantor Fitzgerald raised their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research report on Friday. UBS Group reaffirmed a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research note on Monday, February 9th. Barclays boosted their price target on shares of Cigna Group from $303.00 to $310.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Wells Fargo & Company increased their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $336.20.

Cigna Group Trading Down 2.6%

CI stock traded down $7.44 during trading on Friday, hitting $283.14. The company had a trading volume of 1,519,233 shares, compared to its average volume of 1,415,385. The company has a quick ratio of 0.74, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average price of $274.34 and a 200-day moving average price of $276.94. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a market cap of $74.62 billion, a price-to-earnings ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts predict that Cigna Group will post 30.35 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 28.13%.

Insider Buying and Selling

In related news, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new stake in Cigna Group during the 4th quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its stake in Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the period. Capital Research Global Investors increased its holdings in shares of Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Dodge & Cox raised its position in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Finally, Boston Partners raised its position in shares of Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after purchasing an additional 1,243,056 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.